The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2a
Abstract Trimethylamine oxide (TMAO) is a newly found intestinal microbiota metabolite. Here, we aimed to explore the effects of TMAO on calcium homeostasis and its implication in cardiac hypertrophy, especially focusing on the regulatory mechanism of TMAO on the key calcium transporter SERCA2a. Ech...
Saved in:
| Main Authors: | Dongyu Lei, Yi Liu, Yuan Liu, Yujie Jiang, Yuyan Lei, Feilong Zhao, Wenqun Li, Zhonghua Ouyang, Lulu Chen, Siyuan Tang, Dongsheng Ouyang, Xiaohui Li, Ying Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-025-08016-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The microbial metabolite trimethylamine N-oxide and the kidney diseases
by: Jin-Qi Su, et al.
Published: (2025-03-01) -
Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
by: Zhen Li, et al.
Published: (2024-11-01) -
The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis
by: Fei Guo, et al.
Published: (2020-01-01) -
Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01) -
Development and Application of a UPLC–MRM–MS Method for Quantifying Trimethylamine, Trimethylamine-N-Oxide, and Related Metabolites in Individuals with and Without Metabolic Syndrome
by: Mohammed E. Hefni, et al.
Published: (2025-02-01)